An Approach to DUB - PowerPoint PPT Presentation

About This Presentation
Title:

An Approach to DUB

Description:

... Ultrasound Used to assess endometrial thickness Thickness most useful in postmenopausal women 5mm suggestive of endometrial disease Endometrial thickness ... – PowerPoint PPT presentation

Number of Views:99
Avg rating:3.0/5.0
Slides: 13
Provided by: JohnF225
Category:

less

Transcript and Presenter's Notes

Title: An Approach to DUB


1
An Approach to DUB
  • Cynthia Phelan PGY 1
  • 2003 / 08 / 05

2
Dysfunctional Uterine Bleeding
  • Normal Menstrual Cycle
  • 28 /- 7 days
  • 4 /- 2 days
  • Blood loss 40 /- 20ml

3
Diagnosis
  • History
  • Is it Uterine?
  • Anovulatory
  • Intermenstrual Bleeding, Irregular cycles
  • Ovulatory
  • Heavy blood loss, Regular Cycles, PMS
  • ? Pathology
  • Pelvic Pain, Post-coital Bleeding, Irregular
    Bleeding
  • Family History
  • Coagulopathy

4
Diagnosis
  • Physical Exam
  • Abdominal Exam
  • Pelvic Exam
  • Pap Test
  • Lab Tests
  • CBC /- Ferritin
  • Other
  • TSH
  • Prolactin day 21-23 to verify ovulatory status
  • FSH/LH - ?menopause
  • Coagulation Profile

5
Investigations
  • Sample endometrium in all patients at risk for
    endometrial cancer.
  • Risk Factors
  • Age gt45
  • Obesity gt90kg
  • Family History
  • Nullpartiy / Infertility
  • PCO
  • Tamoxifen
  • New Onset Heavy Irregular Bleeding
  • Test all women with no symptomatic improvement
    after three months of therapy.

6
Endometrial Sampling
  • Office Biopsy
  • Adequate Sample 87-97
  • Detection Rate 67-96
  • Hysteroscopic Directed Sampling
  • Detects a higher percentage of abnormalities than
    DC
  • DC
  • Reserve for patients in whom biopsy or
    hysteroscopy was unsuccessful.
  • Higher risk procedure anesthesia, perforation

7
(No Transcript)
8
Ultrasound
  • Used to assess endometrial thickness
  • Thickness most useful in postmenopausal women
  • gt5mm suggestive of endometrial disease
  • Endometrial thickness much less useful in
    perimenopausal women and women of reproductive
    age
  • Localization of polyps and myomata

9
Medical Management
  • Conjugated Estrogens
  • Used IV or IM or PO for management of heavy
    bleeding
  • Can be used in both ovulatory and anovulatory
    bleeding
  • NSAIDS
  • ? prostaglandins, ? blood loss by 20-50, improve
    dysmenorrhea
  • Should be taken for five days during menstruation
    each cycle
  • OCP
  • Induce endometrial atrophy ? decreased blood loss
  • Additional advantages contraception, ?
    dysmenorrhea
  • Progestins
  • Cyclic progestins ineffective for heavy bleeding
  • Helpful for women with irregular cycles

10
Medical Management
  • Progestin IUD
  • IUD impregnated with levonorgesterel reported to
    reduce menstrual bleeding
  • Antifibrinolytics
  • Tranexamic acid (cyclokapron)
  • Blocks plasminogen, no reported effect on
    coagulation
  • 1g q6h x4 days at onset of menstrual cycle ?
    blood loss by 40
  • Danazol
  • Mildly androgenic
  • ? steroidogenesis in ovary ? oligo or amenorrhea
    in 90
  • GnRH Agonist
  • Create hypoestrogenic state ? decreased uterine
    volume
  • Volume returns to normal after cessation of
    treatment
  • Side effects often not tolerated hot flashes,
    bone density

11
Surgery
  • DC
  • Endometrial Ablation
  • Hysterectomy

12
Take Home Points
  • Investigate for polyps and fibroids
  • All patients should have a pap and CBC
  • Endometrial biopsy should be done on all women at
    high risk for endometrial ca.
Write a Comment
User Comments (0)
About PowerShow.com